BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31307585)

  • 1. Mechanisms of idiosyncratic drug-induced liver injury.
    Uetrecht J
    Adv Pharmacol; 2019; 85():133-163. PubMed ID: 31307585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiosyncratic Drug-Induced Liver Injury: Mechanistic and Clinical Challenges.
    Jee A; Sernoskie SC; Uetrecht J
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic Studies of Idiosyncratic DILI: Clinical Implications.
    Uetrecht J
    Front Pharmacol; 2019; 10():837. PubMed ID: 31402866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Reactive Metabolites Induce an Immune Response That Sometimes Leads to an Idiosyncratic Drug Reaction.
    Cho T; Uetrecht J
    Chem Res Toxicol; 2017 Jan; 30(1):295-314. PubMed ID: 27775332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune mechanisms of idiosyncratic drug-induced liver injury.
    Mak A; Uetrecht J
    J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
    Mak A; Kato R; Weston K; Hayes A; Uetrecht J
    Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do In Vitro Assays Predict Drug Candidate Idiosyncratic Drug-Induced Liver Injury Risk?
    Kenna JG; Uetrecht J
    Drug Metab Dispos; 2018 Nov; 46(11):1658-1669. PubMed ID: 30021844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned from animal models of idiosyncratic, drug-induced liver injury?
    Roth RA; Ganey PE
    Expert Opin Drug Metab Toxicol; 2020 Jun; 16(6):475-491. PubMed ID: 32324077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Injury Caused by Green Tea Extract in PD-1
    Cho T; Wang X; Yeung K; Cao Y; Uetrecht J
    Chem Res Toxicol; 2021 Mar; 34(3):849-856. PubMed ID: 33617238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
    Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
    J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes.
    Kato R; Uetrecht J
    Chem Res Toxicol; 2017 Jun; 30(6):1327-1332. PubMed ID: 28525267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury.
    Mak A; Uetrecht J
    J Immunotoxicol; 2015; 12(4):361-7. PubMed ID: 25425471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury.
    Mak A; Cho T; Uetrecht J
    J Immunotoxicol; 2018 Dec; 15(1):90-95. PubMed ID: 29733743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury.
    Mak A; Uetrecht J
    J Immunotoxicol; 2019 Dec; 16(1):28-33. PubMed ID: 30663942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal models of idiosyncratic drug-induced liver injury--current status.
    Roth RA; Ganey PE
    Crit Rev Toxicol; 2011 Oct; 41(9):723-39. PubMed ID: 21726137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Westra IM; Starokozhko V; Dragovic S; Merema MT; Groothuis GM
    Chem Res Toxicol; 2013 May; 26(5):710-20. PubMed ID: 23565644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury.
    Cho T; Wang X; Uetrecht J
    Chem Res Toxicol; 2019 Jul; 32(7):1423-1431. PubMed ID: 31251588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM
    Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury.
    Mak A; Johnston A; Uetrecht J
    J Immunotoxicol; 2017 Dec; 14(1):89-94. PubMed ID: 28279082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.